Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a+/− mouse model

Accentuated right ventricular (RV) gradients in action potential duration (APD) have been implicated in the arrhythmogenicity observed in Brugada syndrome in studies assuming that ventricular effective refractory periods (VERPs) vary in concert with APDs. The present experiments use a genetically modified mouse model to explore spatial heterogeneities in VERP that in turn might affect conduction velocity, thereby causing arrhythmias. Activation latencies, APDs and VERPs recorded during programmed S1S2 protocols were compared in RV and left ventricular (LV) epicardia and endocardia of Langendorff-perfused wild-type (WT) and Scn5a+/− hearts. Scn5a+/− and WT hearts showed similar patterns of shorter VERPs in RV than LV epicardia, and in epicardia than endocardia. However, Scn5a+/− hearts showed longer VERPs, despite shorter APD90s, than WT in all regions examined. The pro- and anti-arrhythmic agents flecainide and quinidine increased regional VERPs despite respectively decreasing and increasing the corresponding APD90s particularly in Scn5a+/− RV epicardia. In contrast, Scn5a+/− hearts showed greater VERP gradients between neighbouring regions, particularly RV transmural gradients, than WT (9.1 ± 1.1 vs. 5.7 ± 0.5 ms, p < 0.05, n = 12). Flecainide increased (to 21 ± 0.9 ms, p < 0.05, n = 6) but quinidine decreased (to 4.5 ± 0.5 ms, p < 0.05, n = 6) these gradients, particularly across the Scn5a+/− RV. Finally, Scn5a+/− hearts showed greater conduction slowing than WT following S2 stimuli, particularly with flecainide administration. Rather than arrhythmogenesis resulting from increased transmural repolarization gradients in an early, phase 2, reentrant excitation mechanism, the present findings implicate RV VERP gradients in potential reentrant mechanisms involving impulse conduction slowed by partial refractoriness

Arrhythmia mechanisms in acute ischaemia and chronic infarction in rabbit heart

In this thesis, a method for studying the electrophysiological consequences of acute regional ischaemia in rabbit heart was established using a combination of a novel snare technique and optical mapping. The purpose of this approach was to discover the mechanistic link between acute coronary infarction and the occurrence of arrhythmias. The electrophysiology of the epicardial surface of isolated hearts was examined using the voltage sensitive dye RH237 and optical action potentials were recorded from a 13x13mm area of left ventricular epicardium using a 16x16 element Hamamatsu photodiode array. Contraction motion artefacts were practically eliminated with blebbistatin (5µM). An alternative mechanical uncoupler, BDM, was found to be not suitable for the study of arrhythmic behaviour associated with ischaemia. After occlusion of the left coronary artery, a progressive reduction in action potential duration (APD), and slowing of upstroke was observed in an area of the left ventricle anterior surface, accompanied by ECG S-T segment elevation. These effects were reversed when the coronary artery occlusion was released. Ligation (duration 12-15mins) caused a decrease in APD50 (APD at 50% repolarisation), in the zone of reduced perfusion, from 141±5.2ms to 53.3±9.3ms (mean±SEM, n=10 hearts, P<0.001). After ligation was reversed and full perfusion restored, APD50 returned to normal values (149±7.0ms, n.s.). Trise (action potential rise time from 10-90% depolarisation) increased from 7.2±1.0ms to 15.8±2.8ms (P<0.01). In the non-infarcted area of myocardium, no significant changes in APD50 (147±7.0ms vs. 147±8.1ms) or Trise (6.4±0.4ms vs 8.8±1.4ms) were observed during occlusion. T-wave alternans behaviour was observed frequently during local ischaemia and associated with alternans of optical action potentials (OAPs) in the ischaemic border zone (BZ) and in ischaemic zone (IZ). T-wave alternans amplitude was not maintained during local ischaemia but OAPs continued to show alternating behaviour. Arrhythmias (VT and VF) were common when conduction block occurred at the interface between the normal and ischaemic zone, but arrhythmias were absent when conduction into the IZ was retained. This observation suggests that the conduction block was the crucial precipitating event for the generation of arrhythmias. Acute local ischaemia was also imposed in a heart with an existing infarct scar to examine the effects of pre-existing ischaemic damage. The incidence of arrhythmias was similar to that observed in the absence of an infarct scar indicating that pre-existing damage did not predispose the heart to arrhythmias. Global ischaemic challenges, both low flow and zero flow produced similar reductions in APD and rise time and were followed by arrhythmias, but the associated changes in the ECG were complex and could not be easily interpreted. Significant temporal variability in electrophysiology was observed in global ischaemia, but absent in the local ischaemic challenge. The underlying mechanisms of these temporal flucuations in cardiac electrophysiology may be dictated by either cellular metabolism or fluctuations in coronary flow. Long-term local ischaemia (~60mins) did not reveal a second phase of arrhythmias after 40-45mins as observed in other animal models, and nor were there signs of significant further electrophysiological changes as a consequence of the additional period of local ischaemia

Modelling the interaction between induced pluripotent stem cells derived cardiomyocytes patches and the recipient hearts

Cardiovascular diseases are the main cause of death worldwide. The single biggest killer is represented by ischemic heart disease. Myocardial infarction causes the formation of non-conductive and non-contractile, scar-like tissue in the heart, which can hamper the heart's physiological function and cause pathologies ranging from arrhythmias to heart failure. The heart can not recover the tissue lost due to myocardial infarction due to the myocardium's limited ability to regenerate. The only available treatment is heart transpalant, which is limited by the number of donors and can elicit an adverse response from the recipients immune system. Recently, regenerative medicine has been proposed as an alternative approach to help post-myocardial infarction hearts recover their functionality. Among the various techniques, the application of cardiac patches of engineered heart tissue in combination with electroactive materials constitutes a promising technology. However, many challenges need to be faced in the development of this treatment. One of the main concerns is represented by the immature phenotype of the stem cells-derived cardiomyocytes used to fabricate the engineered heart tissue. Their electrophysiological differences with respect to the host myocardium may contribute to an increased arrhythmia risk. A large number of animal experiments are needed to optimize the patches' characteristics and to better understand the implications of the electrical interaction between patches and host myocardium. In this Thesis we leveraged cardiac computational modelling to simulate \emph{in silico} electrical propagation in scarred heart tissue in the presence of a patch of engineered heart tissue and conductive polymer engrafted at the epicardium. This work is composed by two studies. In the first study we designed a tissue model with simplified geometry and used machine learning and global sensitivity analysis techniques to identify engineered heart tissue patch design variables that are important for restoring physiological electrophysiology in the host myocardium. Additionally, we showed how engineered heart tissue properties could be tuned to restore physiological activation while reducing arrhythmic risk. In the second study we moved to more realistic geometries and we devised a way to manipulate ventricle meshes obtained from magnetic resonance images to apply \emph{in silico} engineered heart tissue epicardial patches. We then investigated how patches with different conduction velocity and action potential duration influence the host ventricle electrophysiology. Specifically, we showed that appropriately located patches can reduce the predisposition to anatomical isthmus mediated re-entry and that patches with a physiological action potential duration and higher conduction velocity were most effective in reducing this risk. We also demonstrated that patches with conduction velocity and action potential duration typical of immature stem cells-derived cardiomyocytes were associated with the onset of sustained functional re-entry in an ischemic cardiomyopathy model with a large transmural scar. Finally, we demonstrated that patches electrically coupled to host myocardium reduce the likelihood of propagation of focal ectopic impulses. This Thesis demonstrates how computational modelling can be successfully applied to the field of regenerative medicine and constitutes the first step towards the creation of patient-specific models for developing and testing patches for cardiac regeneration.Open Acces

Evaluation of QTc before and after exercise testing in a population of patients with severe obesity: possible association with obstructive sleep apnoea

openObesity is associated with QT interval prolongation. Obesity is also associated with OSA (obstructive sleep apnoea). OSA as well is associated with prolongation of the QT interval. The purpose of this study is to evaluate the QTc before and after exercise testing in a population of patients with severe obesity, and a possible association between QTc prolongation and OSA

Role of the autonomic nervous system in the genesis of cardiac arrhythmias : pathophysiology and therapy implications

Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2021O sistema nervoso autónomo é responsável pela manutenção do normal funcionamento cardíaco, através de vias dinâmicas de feedback aferente e eferente entre os seus diferentes níveis. A doença cardíaca pode levar a um “remodelling” neuronal e disfunção simpatovagal, o que tem sido implicado na iniciação e manutenção de arritmias cardíacas auriculares e ventriculares. Os mecanismos complexos através dos quais a desregulação autonómica predispõe à arritmogénese são diferentes entre arritmias. Na fibrilhação auricular, o aumento da atividade de ambos os sistemas simpático e parassimpático é proarrítmico. Em contraste, na fibrilhação ventricular no contexto de isquemia miocárdica, a ativação simpática é o desencadeante mais comum. Na maioria dos síndromes de arritmias hereditárias, a estimulação simpática induz taquiarritmias ventriculares e morte súbita cardíaca. A identificação de desencadeantes autonómicos específicos tem sugerido que várias terapêuticas de neuromodulação poderão contribuir para a prevenção e tratamento de diferentes arritmias. A neuromodulação é uma terapêutica bem estabelecida no síndrome do QT longo, mas continua ainda sob investigação quanto à sua utilização em outras arritmias. Nesta revisão, iremos apresentar um breve resumo da anatomia e fisiologia básicas do sistema nervoso autónomo cardíaco e explicar o seu papel na patogénese de arritmias cardíacas, incluindo fibrilhação auricular e arritmias ventricualres, particularmente no contexto de isquémia miocárdica e canalopatias hereditárias. Por fim, iremos apresentar os avanços recentes bem como as potenciais limitações da neuromodulação, uma estratégia emergente na gestão de doentes com arritmias refratárias, por permitir restaurar o equilíbrio entre as componentes simpática e parassimpática do sistema nervoso autónomo.The autonomic nervous system is responsible for the maintenance of normal cardiac function, through dynamic afferent and efferent feedback loops between its different levels. Cardiac disease can lead to neural remodelling and sympathovagal imbalances, inducing autonomic dysregulation, which is known to play an important role in the initiation and maintenance of atrial and ventricular cardiac arrhythmias. The complex mechanisms by which autonomic dysregulation predisposes to arrhythmogenesis are different between arrhythmias. In atrial fibrillation, increased activity of both sympathetic and parasympathetic systems is proarrhythmic. In contrast, in ventricular fibrillation in the setting of myocardial ischaemia, sympathetic activation is the most common trigger. In most inherited arrhythmia syndromes, sympathetic stimulation induces ventricular tachyarrhythmias and sudden cardiac death. The identification of specific autonomic triggers has suggested that several neuromodulatory therapies might contribute to the prevention and treatment of different arrhythmias. Neuromodulation is a well-established therapy in long QT syndrome, but it is still under investigation regarding its use in other arrhythmias. In this review, we will present a brief resume of the basic anatomy and physiology of cardiac autonomic nervous system and explain its role in the pathogenesis of cardiac arrhythmias, including atrial fibrillation and ventricular arrhythmias, particularly in the context of myocardial ischaemia and inherited channelopathies. Then, we will present the recent advances as well as the potential limitations of neuromodulation, which is emerging as an alternative in the management of patients with refractory arrhythmias, allowing to restore the balance between sympathetic and parasympathetic branches of the autonomic nervous system

Contribution to the improvement of electrical therapies and to the comprehension of electrophysiological mechanisms in heart failure and acute ischemia using computational simulation

[ES] Una mejor comprensión de los mecanismos subyacentes a las arritmias ventriculares, así como una mejora de las terapias eléctricas y farmacológicas asociadas, son un factor clave para prevenir la muerte súbita cardíaca en pacientes con cardiopatías estructurales y eléctricas. Una miocardiopatía importante que puede provocar arritmias ventriculares potencialmente mortales es la insuficiencia cardíaca (HF). Los pacientes con HF a menudo sufren también de bloqueo de rama izquierda (LBBB) que deteriora su condición. Actualmente, el tratamiento más eficaz para estos pacientes es la terapia de resincronización cardíaca (CRT). Sin embargo, no se alcanza una respuesta positiva en todos los casos, por lo que es necesario un mayor estudio para mejorar este tratamiento. Una segunda patología cardíaca que también produce arritmias letales es la isquemia miocárdica. Evidencia experimental ha demostrado que las alteraciones electrofisiológicas en el miocardio ventricular constituyen un sustrato para la generación de arritmias durante la fase aguda de isquemia. Estas alteraciones son inducidas por los tres componentes isquémicos principales: hipercalemia, hipoxia y acidosis. Sin embargo, la influencia de cada componente en los mecanismos de inicio y mantenimiento de las arritmias no se comprende aún con claridad. Una primera parte de esta tesis doctoral, se centra en la optimización de la CRT durante su aplicación en un corazón que padece HF y LBBB. Para esto, se modificó el modelo de potencial de acción (AP) de O'Hara para simular una velocidad de conducción realista tanto en condiciones sanas como patológicas. Además, se estimó e incorporó un sistema de His-Purkinje (HPS) dentro de un modelo biventricular/torso humano 3D para simular un LBBB realista. A continuación, se desarrolló un conjunto de simulaciones computacionales para diferentes configuraciones de la CRT a fin de determinar la posición y el instante de estimulación óptimo que conducen a la duración más corta del QRS. Posteriormente, los resultados se compararon con otros criterios de optimización. Los principales hallazgos de este estudio mostraron la necesidad de definir criterios de optimización mejores o complementarios, como un índice basado en el tiempo hasta alcanzar el 90% del área del QRS sugerido en este trabajo, para alcanzar la mejor sincronía eléctrica ventricular durante la aplicación de la CRT. Además, nuestros resultados también muestran que el septo superior cercano al tracto de salida es un sitio alternativo para la estimulación del ventrículo derecho, lo cual evita los problemas de perforación de la pared apical durante el procedimiento típico de la CRT. Por último, para obtener mejores resultados de la CRT se deben considerar protocolos de estimulación endocárdica en el ventrículo izquierdo. En la segunda parte de esta tesis se investigó los efectos de los tres componentes principales de la isquemia sobre la vulnerabilidad a una reentrada, así como el papel del HPS y sus mecanismos de acción en la generación y mantenimiento de arritmias ventriculares. Para lograr este objetivo, en primer lugar, se modificó el modelo AP ventricular para simular de forma realista las principales alteraciones provocadas por la isquemia miocárdica aguda. Las simulaciones se realizaron en un modelo biventricular humano 3D, acoplado en un torso virtual, que incluye una geometría realista de las zonas isquémicas central y de borde, así como un HPS detallado. Se simularon cuatro escenarios de severidad isquémica correspondientes a diferentes minutos de oclusión de la arteria coronaria para evaluar los efectos de la evolución de la isquemia en el tiempo. Luego, se evaluó la influencia individual de la hipercalemia, hipoxia y acidosis en el ancho de la ventana vulnerable (VW) a reentradas durante siete escenarios de isquemia aguda. Finalmente, se repitió este último conjunto de simulaciones isquémicas utilizando el modelo anatómico sin el HPS para evaluar el efecto de este último en la VW. Los resultados muestran que una condición isquémica moderada es el peor escenario para la generación de una reentrada. La hipoxia es el componente isquémico con el efecto más significativo en el ancho de la VW. Además, el flujo de corriente retrógrado desde el miocardio hacia el HPS en la región isquémica, los bloqueos de conducción en secciones discretas del HPS y el grado de hiperkalemia que afecta a las células de Purkinje, son sugeridos como mecanismos que podrían favorecer la aparición de arritmias ventriculares.[EN] A better understanding of the mechanisms underlying ventricular arrhythmias, as well as an improvement of the associated electrical and pharmacological therapies, are a key factor to prevent sudden cardiac death in patients with structural and electrical heart diseases. An important cardiomyopathy that can lead to life-threatening ventricular arrhythmias is heart failure (HF). Patients with HF also often suffer from left bundle branch block (LBBB), which worsens their condition. Currently, the most effective treatment to these patients is cardiac resynchronization therapy (CRT). However, many patients are non-responders, so further studies are needed to improve this treatment. A second cardiac pathology that also produces lethal arrhythmias is myocardial ischemia. Substantial experimental evidence has shown that electrophysiological alterations in the ventricular myocardium constitute a substrate for the generation of arrhythmias during the acute phase of ischemia. These alterations are induced by the three main ischemic components: hyperkalemia, hypoxia and acidosis. However, the influence of each component in the mechanisms of arrhythmia initiation and maintenance is still not completely understood. In the first section of this doctoral thesis, we focus on the optimization of CRT during its application in a heart suffering from HF and LBBB. For this purpose, we modified the O'Hara action potential (AP) model to simulate a realistic conduction velocity both in healthy and pathological conditions. In addition, a His-Purkinje system (HPS) was generated and incorporated into a 3D human biventricular/torso model to simulate realistic LBBB. A set of computational simulations were performed for different CRT configurations to determine the optimal pacing leads location and delay values leading to the shortest QRS duration. Subsequently, results were compared with other optimization criteria. The main findings of this study showed the need of better or complementary optimization criteria, such as an index based on the time to reach the 90% of the QRS area suggested in this work, to reach the best ventricular electrical synchrony during the CRT application. In addition, our results also show that the upper septum close to the outflow tract is an alternative site for the right ventricle (RV) stimulation, which avoids the perforation problems of the RV apical wall during the typical CRT procedure. Finally, protocols of left ventricle endocardial pacing should be considered to obtain better CRT results. In the second section of this thesis, we investigated the effects of the three main components of ischemia on the vulnerability to reentry, as well as the role of the HPS and its mechanisms of action in the generation and maintenance of ventricular arrhythmias. In order to achieve our goal, we first modified the ventricular AP model to realistically simulate the major alterations caused by acute myocardial ischemia. Simulations were performed in a 3D human biventricular model, embedded in a virtual torso, which includes a realistic geometry of the central and border ischemic zones, as well as a detailed HPS. Four scenarios of ischemic severity corresponding to different minutes after coronary artery occlusion were simulated to evaluate the effects of the evolution of ischemia over time. Then, the individual influence of hyperkalemia, hypoxia and acidosis in the width of the vulnerable window (VW) for reentry was assessed during seven scenarios of acute ischemia. Finally, this last set of ischemic simulations was repeated using the anatomical model without the HPS to evaluate the effect of the latter in the VW. Results show that a moderate ischemic condition is the worst scenario for reentry generation. Hypoxia is the ischemic component with the most significant effect on the width of the VW. Furthermore, the retrograde current flow from the myocardium to the HPS in the ischemic region, conduction blocks in discrete sections of the HPS, and the degree of hyperkalemia affecting the Purkinje cells, are suggested as HPS mechanisms that could favor the triggering of ventricular arrhythmias.[CA] Una millor comprensió dels mecanismes subjacents a les arrítmies ventriculars, així com una millora de les teràpies elèctriques i farmacològiques associades, són un factor clau per a previndre la mort sobtada cardíaca en pacients amb cardiopaties estructurals i elèctriques. Una miocardiopatia important que pot provocar arrítmies ventriculars potencialment mortals és la insuficiència cardíaca (HF). Els pacients amb HF sovint pateixen també de bloqueig de branca esquerra (LBBB) que deteriora la seua condició. Actualment, el tractament més eficaç per a aquests pacients és la teràpia de resincronització cardíaca (CRT). No obstant això, no s'aconsegueix una resposta positiva en tots els casos, per la qual cosa és necessari un major estudi per a millorar aquest tractament. Una segona patologia cardíaca que també produeix arrítmies letals és la isquèmia miocàrdica. Evidència experimental ha demostrat que les alteracions electrofisiològiques en el miocardi ventricular constitueixen un substrat per a la generació d'arrítmies durant la fase aguda d'isquèmia. Aquestes alteracions són induïdes pels tres components isquèmics principals: hipercalèmia, hipòxia i acidosi. No obstant això, la influència de cada component en els mecanismes d'inici i manteniment de les arrítmies no es comprén encara amb claredat. Una primera part d'aquesta tesi doctoral, se centra en l'optimització de la CRT durant la seua aplicació en un cor que pateix HF i LBBB. Per a això, es va modificar el model de potencial d'acció (AP) de O'Hara per a simular una velocitat de conducció realista tant en condicions sanes com patològiques. A més, es va estimar i es va incorporar un sistema de His-Purkinje (HPS) dins d'un model biventricular/tors humà 3D per a simular un LBBB realista. A continuació, es va desenvolupar un conjunt de simulacions computacionals per a diferents configuracions de la CRT a fi de determinar la posició i l'instant d'estimulació òptim que condueixen a la duració més curta del QRS. Posteriorment, els resultats es van comparar amb altres criteris d'optimització. Les principals troballes d'aquest estudi van mostrar la necessitat de definir millors o complementaris criteris d'optimització, com un índex basat en el temps fins a aconseguir el 90% de l'àrea del QRS suggerida en aquest treball, per a aconseguir la millor sincronia elèctrica ventricular durant l'aplicació de la CRT. A més, els nostres resultats també mostren que el septe superior pròxim al tracte d'eixida és un lloc alternatiu per a l'estimulació del ventricle dret, la cual cosa evita els problemes de perforació de la paret apical durant el procediment típic de la CRT. Finalment, per a obtindre millors resultats de la CRT s'han de considerar protocols d'estimulació endocárdica en el ventricle esquerre. En la segona part d'aquesta tesi es va investigar els efectes dels tres components principals de la isquèmia sobre la vulnerabilitat a una reentrada, així com el paper del HPS i els seus mecanismes d'acció en la generació i manteniment d'arrítmies ventriculars. Per a aconseguir aquest objectiu, en primer lloc es va modificar el model AP ventricular per a simular de manera realista les principals alteracions provocades per la isquèmia miocàrdica aguda. Les simulacions es van realitzar en un model biventricular humà 3D, acoblat en un tors virtual, que inclou una geometria realista de les zones isquèmiques central i de vora, així com un HPS detallat. Es van simular quatre escenaris de severitat isquèmica corresponents a diferents minuts d'oclusió de l'artèria coronària per a avaluar els efectes de l'evolució de la isquèmia en el temps. Després, es va avaluar la influència individual de la hipercalèmia, hipòxia i acidosi en l'ample de la finestra vulnerable (VW) a reentradas durant set escenaris d'isquèmia aguda. Finalment, es va repetir aquest últim conjunt de simulacions isquèmiques utilitzant el model anatòmic sense el HPS per a avaluar l'efecte d'aquest últim en la VW. Els resultats mostren que una condició isquèmica moderada és el pitjor escenari per a la generació d'una reentrada. La hipòxia és el component isquèmic amb l'efecte més significatiu en l'ample de la VW. A més, el flux de corrent retrògrad des del miocardi cap al HPS a la regió isquèmica, els bloquejos de conducció en seccions discretes del HPS i el grau d'hiperkalèmia que afecta les cèl·lules de Purkinje, són suggerits com a mecanismes que podrien afavorir l'aparició d'arrítmies ventriculars.Carpio Garay, EF. (2021). Contribution to the improvement of electrical therapies and to the comprehension of electrophysiological mechanisms in heart failure and acute ischemia using computational simulation [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/163041TESI

Computational modelling of the human heart and multiscale simulation of its electrophysiological activity aimed at the treatment of cardiac arrhythmias related to ischaemia and Infarction

[ES] Las enfermedades cardiovasculares constituyen la principal causa de morbilidad y mortalidad a nivel mundial, causando en torno a 18 millones de muertes cada año. De entre ellas, la más común es la enfermedad isquémica cardíaca, habitualmente denominada como infarto de miocardio (IM). Tras superar un IM, un considerable número de pacientes desarrollan taquicardias ventriculares (TV) potencialmente mortales durante la fase crónica del IM, es decir, semanas, meses o incluso años después la fase aguda inicial. Este tipo concreto de TV normalmente se origina por una reentrada a través de canales de conducción (CC), filamentos de miocardio superviviente que atraviesan la cicatriz del infarto fibrosa y no conductora. Cuando los fármacos anti-arrítmicos resultan incapaces de evitar episodios recurrentes de TV, la ablación por radiofrecuencia (ARF), un procedimiento mínimamente invasivo realizado mediante cateterismo en el laboratorio de electrofisiología (EF), se usa habitualmente para interrumpir de manera permanente la propagación eléctrica a través de los CCs responsables de la TV. Sin embargo, además de ser invasivo, arriesgado y requerir mucho tiempo, en casos de TVs relacionadas con IM crónico, hasta un 50% de los pacientes continúa padeciendo episodios recurrentes de TV tras el procedimiento de ARF. Por tanto, existe la necesidad de desarrollar nuevas estrategias pre-procedimiento para mejorar la planificación de la ARF y, de ese modo, aumentar esta tasa de éxito relativamente baja. En primer lugar, realizamos una revisión exhaustiva de la literatura referente a los modelos cardiacos 3D existentes, con el fin de obtener un profundo conocimiento de sus principales características y los métodos usados en su construcción, con especial atención sobre los modelos orientados a simulación de EF cardíaca. Luego, usando datos clínicos de un paciente con historial de TV relacionada con infarto, diseñamos e implementamos una serie de estrategias y metodologías para (1) generar modelos computacionales 3D específicos de paciente de ventrículos infartados que puedan usarse para realizar simulaciones de EF cardíaca a nivel de órgano, incluyendo la cicatriz del infarto y la región circundante conocida como zona de borde (ZB); (2) construir modelos 3D de torso que permitan la obtención del ECG simulado; y (3) llevar a cabo estudios in-silico de EF personalizados y pre-procedimiento, tratando de replicar los verdaderos estudios de EF realizados en el laboratorio de EF antes de la ablación. La finalidad de estas metodologías es la de localizar los CCs en el modelo ventricular 3D para ayudar a definir los objetivos de ablación óptimos para el procedimiento de ARF. Por último, realizamos el estudio retrospectivo por simulación de un caso, en el que logramos inducir la TV reentrante relacionada con el infarto usando diferentes configuraciones de modelado para la ZB. Validamos nuestros resultados mediante la reproducción, con una precisión razonable, del ECG del paciente en TV, así como en ritmo sinusal a partir de los mapas de activación endocárdica obtenidos invasivamente mediante sistemas de mapeado electroanatómico en este último caso. Esto permitió encontrar la ubicación y analizar las características del CC responsable de la TV clínica. Cabe destacar que dicho estudio in-silico de EF podría haberse efectuado antes del procedimiento de ARF, puesto que nuestro planteamiento está completamente basado en datos clínicos no invasivos adquiridos antes de la intervención real. Estos resultados confirman la viabilidad de la realización de estudios in-silico de EF personalizados y pre-procedimiento de utilidad, así como el potencial del abordaje propuesto para llegar a ser en un futuro una herramienta de apoyo para la planificación de la ARF en casos de TVs reentrantes relacionadas con infarto. No obstante, la metodología propuesta requiere de notables mejoras y validación por medio de es[CA] Les malalties cardiovasculars constitueixen la principal causa de morbiditat i mortalitat a nivell mundial, causant entorn a 18 milions de morts cada any. De elles, la més comuna és la malaltia isquèmica cardíaca, habitualment denominada infart de miocardi (IM). Després de superar un IM, un considerable nombre de pacients desenvolupen taquicàrdies ventriculars (TV) potencialment mortals durant la fase crònica de l'IM, és a dir, setmanes, mesos i fins i tot anys després de la fase aguda inicial. Aquest tipus concret de TV normalment s'origina per una reentrada a través dels canals de conducció (CC), filaments de miocardi supervivent que travessen la cicatriu de l'infart fibrosa i no conductora. Quan els fàrmacs anti-arítmics resulten incapaços d'evitar episodis recurrents de TV, l'ablació per radiofreqüència (ARF), un procediment mínimament invasiu realitzat mitjançant cateterisme en el laboratori de electrofisiologia (EF), s'usa habitualment per a interrompre de manera permanent la propagació elèctrica a través dels CCs responsables de la TV. No obstant això, a més de ser invasiu, arriscat i requerir molt de temps, en casos de TVs relacionades amb IM crònic fins a un 50% dels pacients continua patint episodis recurrents de TV després del procediment d'ARF. Per tant, existeix la necessitat de desenvolupar noves estratègies pre-procediment per a millorar la planificació de l'ARF i, d'aquesta manera, augmentar la taxa d'èxit, que es relativament baixa. En primer lloc, realitzem una revisió exhaustiva de la literatura referent als models cardíacs 3D existents, amb la finalitat d'obtindre un profund coneixement de les seues principals característiques i els mètodes usats en la seua construcció, amb especial atenció sobre els models orientats a simulació de EF cardíaca. Posteriorment, usant dades clíniques d'un pacient amb historial de TV relacionada amb infart, dissenyem i implementem una sèrie d'estratègies i metodologies per a (1) generar models computacionals 3D específics de pacient de ventricles infartats capaços de realitzar simulacions de EF cardíaca a nivell d'òrgan, incloent la cicatriu de l'infart i la regió circumdant coneguda com a zona de vora (ZV); (2) construir models 3D de tors que permeten l'obtenció del ECG simulat; i (3) dur a terme estudis in-silico de EF personalitzats i pre-procediment, tractant de replicar els vertaders estudis de EF realitzats en el laboratori de EF abans de l'ablació. La finalitat d'aquestes metodologies és la de localitzar els CCs en el model ventricular 3D per a ajudar a definir els objectius d'ablació òptims per al procediment d'ARF. Finalment, a manera de prova de concepte, realitzem l'estudi retrospectiu per simulació d'un cas, en el qual aconseguim induir la TV reentrant relacionada amb l'infart usant diferents configuracions de modelatge per a la ZV. Validem els nostres resultats mitjançant la reproducció, amb una precisió raonable, del ECG del pacient en TV, així com en ritme sinusal a partir dels mapes d'activació endocardíac obtinguts invasivament mitjançant sistemes de mapatge electro-anatòmic en aquest últim cas. Això va permetre trobar la ubicació i analitzar les característiques del CC responsable de la TV clínica. Cal destacar que aquest estudi in-silico de EF podria haver-se efectuat abans del procediment d'ARF, ja que el nostre plantejament està completament basat en dades clíniques no invasius adquirits abans de la intervenció real. Aquests resultats confirmen la viabilitat de la realització d'estudis in-silico de EF personalitzats i pre-procediment d'utilitat, així com el potencial de l'abordatge proposat per a arribar a ser en un futur una eina de suport per a la planificació de l'ARF en casos de TVs reentrants relacionades amb infart. No obstant això, la metodologia proposada requereix de notables millores i validació per mitjà d'estudis de simulació amb grans cohorts de pacients.[EN] Cardiovascular diseases represent the main cause of morbidity and mortality worldwide, causing around 18 million deaths every year. Among these diseases, the most common one is the ischaemic heart disease, usually referred to as myocardial infarction (MI). After surviving to a MI, a considerable number of patients develop life-threatening ventricular tachycardias (VT) during the chronic stage of the MI, that is, weeks, months or even years after the initial acute phase. This particular type of VT is typically sustained by reentry through slow conducting channels (CC), which are filaments of surviving myocardium that cross the non-conducting fibrotic infarct scar. When anti-arrhythmic drugs are unable to prevent recurrent VT episodes, radiofrequency ablation (RFA), a minimally invasive procedure performed by catheterization in the electrophysiology (EP) laboratory, is commonly used to interrupt the electrical conduction through the CCs responsible for the VT permanently. However, besides being invasive, risky and time-consuming, in the cases of VTs related to chronic MI, up to 50% of patients continue suffering from recurrent VT episodes after the RFA procedure. Therefore, there exists a need to develop novel pre-procedural strategies to improve RFA planning and, thereby, increase this relatively low success rate. First, we conducted an exhaustive review of the literature associated with the existing 3D cardiac models in order to gain a deep knowledge about their main features and the methods used for their construction, with special focus on those models oriented to simulation of cardiac EP. Later, using a clinical dataset of a chronically infarcted patient with a history of infarct-related VT, we designed and implemented a number of strategies and methodologies to (1) build patient-specific 3D computational models of infarcted ventricles that can be used to perform simulations of cardiac EP at the organ level, including the infarct scar and the surrounding region known as border zone (BZ); (2) construct 3D torso models that enable to compute the simulated ECG; and (3) carry out pre-procedural personalized in-silico EP studies, trying to replicate the actual EP studies conducted in the EP laboratory prior to the ablation. The goal of these methodologies is to allow locating the CCs into the 3D ventricular model in order to help in defining the optimal ablation targets for the RFA procedure. Lastly, as a proof-of-concept, we performed a retrospective simulation case study, in which we were able to induce an infarct-related reentrant VT using different modelling configurations for the BZ. We validated our results by reproducing with a reasonable accuracy the patient's ECG during VT, as well as in sinus rhythm from the endocardial activation maps invasively recorded via electroanatomical mapping systems in this latter case. This allowed us to find the location and analyse the features of the CC responsible for the clinical VT. Importantly, such in-silico EP study might have been conducted prior to the RFA procedure, since our approach is completely based on non-invasive clinical data acquired before the real intervention. These results confirm the feasibility of performing useful pre-procedural personalized in-silico EP studies, as well as the potential of the proposed approach to become a helpful tool for RFA planning in cases of infarct-related reentrant VTs in the future. Nevertheless, the developed methodology requires further improvements and validation by means of simulation studies including large cohorts of patients.During the carrying out of this doctoral thesis, the author Alejandro Daniel López Pérez was financially supported by the Ministerio de Economía, Industria y Competitividad of Spain through the program Ayudas para contratos predoctorales para la formación de doctores, with the grant number BES-2013-064089.López Pérez, AD. (2019). Computational modelling of the human heart and multiscale simulation of its electrophysiological activity aimed at the treatment of cardiac arrhythmias related to ischaemia and Infarction [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/124973TESI

Ventricular fibrillation in ischaemia and its defibrillation

ECG signals were recorded from isolated, Langendorff-perfused rabbit hearts to establish the relationship between dominant frequency and myocardial perfusion during ventricular fibrillation. Lower perfusion rates produced faster rates of dominant frequency decline, to lower steady state values. Optically mapping the anterior epicardial surface demonstrated heterogeneity of dominant frequency in ventricular fibrillation. During low-flow ischaemia, the dominant frequency reduction was restricted to the left ventricle. Application of individual ischaemic components during ventricular fibrillation demonstrated that raised [K+]EC, but not hypoxia or acidic pHEC, reproduced the ischaemic reduction of dominant frequency in the ECG, pseudoECG and over the left ventricular epicardial surface. In contrast, minimum defibrillation energies were increased by hypoxia and acidic pHEC, and not by raised [K+]EC. The dominant frequency heterogeneity during ventricular fibrillation in low-flow ischaemia and raised [K+]EC was not due to differential prolongation of repolarisation or post-repolarisation refractoriness in the left ventricle. Monophasic action potential studies showed that APD90 was reduced to similar degrees in each ventricle by low-flow ischaemia and raised [K+]EC. Effective refractory period was not altered in either ventricle by either condition. Low-flow ischaemia decreased conduction velocity in the left, but not the right ventricle. Conduction velocities were unaltered by raised [K+]EC in either ventricle. The activation threshold of the left ventricle was increased in low-flow ischaemia and raised [K+]EC, whilst the threshold of the right ventricle was unchanged. The increased activation threshold was associated with decreased upstroke velocity and diastolic depolarisation

Simulating the Effect of Global Cardiac Ischaemia on the Dynamics of Ventricular Arrhythmias in the Human Heart

Cardiac arrhythmias are significant causes of death in the world, and ventricular fibrillation is a very dangerous type of cardiac arrhythmia. Global myocardial ischemia is a consequence of ventricular fibrillation (VF) and has been shown to change the dynamic behaviour of activation waves on the heart. The aim of this thesis is to use computational models to study the behaviour of re-entry in the human ventricles when the heart becomes globally ischaemic. The effects of two ischaemic components (hyperkalaemia and hypoxia) on spiral wave re-entry behaviour in two dimensional (2D) ventricular tissue using two ventricular action potential (AP) models were simulated (Ten Tusscher et al. 2006 (TP06) and O’Hara et al. 2011 (ORd)). A three dimensional (3D) model of the human ventricles is used to examine the influence of each ischaemic component on the stability of ventricular fibrillation. Firstly, the main ventricular AP models relevant to this thesis are reviewed. Then, the current-voltage properties of four different IK(ATP) formulations are examined to assess which formulation was more appropriate to simulate hypoxia/ischaemia. Secondly, how the formulation of IK(ATP) influences cell excitability and AP duration (APD) in models of human ventricular myocytes is studied. Finally, mechanisms underlying ventricular arrhythmia generation under the conditions of ischaemia are investigated

Advances in Electrocardiograms

Electrocardiograms have become one of the most important, and widely used medical tools for diagnosing diseases such as cardiac arrhythmias, conduction disorders, electrolyte imbalances, hypertension, coronary artery disease and myocardial infarction. This book reviews recent advancements in electrocardiography. The four sections of this volume, Cardiac Arrhythmias, Myocardial Infarction, Autonomic Dysregulation and Cardiotoxicology, provide comprehensive reviews of advancements in the clinical applications of electrocardiograms. This book is replete with diagrams, recordings, flow diagrams and algorithms which demonstrate the possible future direction for applying electrocardiography to evaluating the development and progression of cardiac diseases. The chapters in this book describe a number of unique features of electrocardiograms in adult and pediatric patient populations with predilections for cardiac arrhythmias and other electrical abnormalities associated with hypertension, coronary artery disease, myocardial infarction, sleep apnea syndromes, pericarditides, cardiomyopathies and cardiotoxicities, as well as innovative interpretations of electrocardiograms during exercise testing and electrical pacing